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Background: Cervical incompetence is one of the causes of preterm birth and mid-trimester pregnancy loss.
Cervical cerclage is a surgical procedure to treat cervical incompetence. Cervical cerclage reduces the incidence of
preterm birth in women at risk of recurrent preterm birth, without a statistically significant reduction in perinatal
mortality or neonatal morbidity. Multifilament/braided sutures such as Mersilene tape have been traditionally used
for cervical cerclage. Braided sutures, particularly mesh-like non-absorbable sutures, have been associated with an
increased risk of infection and, hence, some obstetricians prefer to use monofilament/non-braided sutures.
However, these claims are not substantiated by any scientific or clinical evidence.
We propose a pilot/feasibility study which will provide the necessary information for planning a definitive trial
investigating the clinical effectiveness of monofilament non-braided suture materials in reducing pregnancy loss
rate following cervical cerclage compared to the traditional multifilament braided sutures.
Methods/Design: Women eligible for elective or ultrasound-indicated cerclage at 12 to 21 + 6 weeks of gestation
will be randomised to having the procedure using either a monofilament non-braided suture (Ethilon) or a
Multifilament braided suture (Mersilene tape) inserted using a McDonald technique. Consent for participation in the
Cerclage outcome by the type of suture (COTS) study will be obtained from each eligible participant.
Clinical trials registration: COTS is registered with the International Standard Research for Clinical Trials
(ISRCTN17866773). Registered on 27 March 2013.
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Cervical incompetence is one of the important causes of
prematurity for which cerclage has been used for many
years. A recent Cochrane review showed a trend to a re-
duction in neonatal death and neonatal morbidity; nei-
ther alone was significant [1]. None of the studies
included in the Cochrane review addressed the question
of the type of suture material, an important determinant
of outcomes of surgical procedures in general. This issue
is of particular relevance because Mersilene tape, the
traditionally used surgical material for cerclage, has been
associated with an increased risk of infection in other
surgical disciplines [2,3]. Indeed, infection is an important* Correspondence: f.israfilbayli@nhs.net
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article, unless otherwise stated.underlying cause for failed cerclage and preterm labour
[4]. It is for this reason that some surgeons use monofila-
ment suture material, although this is not evidence-based.
However, the strength of such suture material and the risk
of it traumatising cervical tissue is a concern for some,
albeit an unsubstantiated one. We conducted a national
survey of Obstetrics and Gynaecology consultants in the
UK, which confirmed variability in practice - the majority
of respondents were using multifilament/braided sutures,
whereas only 16.6% used monofilament non-braided su-
tures. Significantly, 75% of respondents stated that there
was no guidance for which suture material to use within
their unit [5]. We subsequently conducted a systematic re-
view, which identified only two non-randomised studies
(NRS). The NRS meta-analysis demonstrated that non-
braided cervical suture is associated with a significant risk
reduction in pregnancy loss compared to multifilament/tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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0.06 to 0.96) [6].
We hypothesised that the use of monofilament sutures
is associated with reduced risk of foetal loss after cerc-
lage. The aim of this publication is to present the re-
search protocol of a pilot/feasibility study which will
provide the necessary information for planning a defini-
tive trial investigating the clinical effectiveness of mono-
filament non-braided suture materials in reducing
pregnancy loss rate following cervical cerclage compared
to the traditional multifilament braided sutures. Thus
Cerclage outcome by the type of suture (COTS) is a
feasibility/pilot randomised controlled trial (RCT) to in-
form a number of aspects of how the definitive trial may
be optimally delivered.
Strengths and weakness of this study
There are several limitations to the proposed study: the
lack of robust prospective data to undertake a formal
sample size calculation; unavailability of information
about the level of clinician’s engagement; or information
about expected recruitment or attrition rates. Therefore,
we designed this as a pilot feasibility study to provide
the information that will be essential for a future full-
scale trial.
In contrast, there are several strengths to this study in-
cluding the novelty of the research question, the avail-
ability of plausible mechanistic hypotheses and the
prioritisation of the research question by the majority of
clinicians responding to the national review of practice
in relation to cerclage procedures. Moreover, members
of the Royal College of Obstetricians and Gynaecologists
Preterm birth clinical study group and the maternity-
specific patient and public involvement group were in-
volved in the study design and determining outcomes of
relevance.
Methods/design
COTS is a pilot and feasibility RCT comparing monofila-
ment (intervention) sutures versus multifilament (com-
parison) for cervical cerclage (Figure 1).
The study will provide an opportunity to prepare for
the challenges and difficulties within a definitive study.
We are testing the study protocol and planning to facili-
tate a formal sample size calculation for the larger RCT.
The consent for participation in the trial will be ob-
tained from each participant.
Ethical approval
The study has been approved by the Ethics Committee
(Edgbaston Research Ethics Committee). The study has
been approved by Research and Development Depart-
ments in each of the three Units (Birmingham Women’sHospital NHS Foundation Trust, Addenbrooke's Hos-
pital, Sandwell and West Birmingham NHS Trust).
Setting
The pilot and feasibility RCT is conducted in three ma-
ternity centres in the UK in order to assess likely recruit-
ment rates and acceptability across different sites.
Study population and eligibility criteria
Participants consist of women eligible for elective or
ultrasound-indicated cerclage 12 to 21 + 6 weeks of ges-
tation as per Royal College of Obstetricians and Gynae-
cologists guideline [4].
Inclusion criteria
Singleton pregnancies in women:
 With a history of three or more previous mid-
trimester losses or premature (<28 week) births
 Who have had cervical sutures in previous
pregnancies
 With history of mid-trimester loss or premature
birth with a shortened cervix (<25 mm)
 Who are deemed at risk of preterm birth at the
clinician's discretion
Exclusion criteria
 <18 years old
 Multiple pregnancy
 Women who are unable to give informed consent
 Women unwilling to consent to the study
Consent and randomisation
The study will be discussed with the women and they
will be provided with an information leaflet ensuring
they have enough time to read it and discuss it, as cerc-
lage is usually booked as a scheduled procedure on a
separate day.
Patients are reassured about confidentiality, are ad-
vised that declining participation will not affect their
clinical care, and told that they can withdraw the con-
sent at any point in the pathway. To reduce the potential
for bias, computer or telephone randomisation occurs
immediately before surgery. The allocation ratio will be
1:1; randomisation is in blocks.
Intervention
The monofilament non-braided suture used is Ethilon®,
(Ethicon, UK) and the multifilament braided suture is
Mersilene® tape (Ethicon, UK) for the intervention and
control groups, respectively. The stitch is inserted using
a McDonald technique. Planned removal of the suture
would occur at 37 (±1) weeks of gestation. When the
Women eligible for elective or ultrasound indicated 
cerclage12-21+6/40 as per RCOG guideline
Exclusion criteria
Women eligible and consenting to be part of COTS
Randomisation
Intervention non-braided 
monofilament suture 
(Ethilon)
Control braided/ 
multifilament suture 
(Mersilene)
Routine follow up
Primary outcome
Live birth
Secondary outcomes
median gestation at deliver, mode of delivery, length of 
median stay in neonatal unit, median time ventilated, 
length of hospitalisation for paediatric reasons
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Figure 1 Study flow chart. COTS, Cerclage outcome by the type of suture; RCOG, Royal College of Obstetricians and Gynaecologists.
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tigations. A vaginal swab is taken before the cerclage
procedure to ensure that any infection is treated before
inserting the suture. A vaginal swab will also be taken at
the time of suture removal. The follow-up should not in-
volve additional contact with the patient beyond routine
local clinical management protocols. The study will be
deemed complete when the last recruited woman has
delivered and, if applicable, her baby is discharged from
the neonatal unit.
In view of logistic difficulties in ensuring blinding of
participants, and the fact that all the COTS outcomes
are objective measures that would be easily and inde-
pendently retrieved from hospital records (and hence it
is unlikely that the lack of blinding will be a cause of ser-
ious bias), we do not intend to attempt blinding partici-
pants or assessors.
Study outcome measures
Primary outcome
Live birth rate
Secondary outcomes
 Median gestation at delivery
 Mode of delivery
 Length of median stay in neonatal unit
 Median time ventilated
 Length of hospitalisation for paediatric reasons
Withdrawal from COTS study
Participants may withdraw from the study at any time.
Should they choose to withdraw, they will continue to
be followed up, in line with current practice within the
participating unit.
Safety monitoring procedures
Within the COTS trial, a serious adverse event (SAE) is
defined as an untoward occurrence:
 Miscarriage/preterm labour within 24 hours of
cerclage
 Premature rupture of membranes within 48 hours
 Prolongation of existing hospitalisation
 Significant haemorrhage, requiring blood transfusion
 Infection requiring intravenous antibiotics
 Life-threatening conditions
 Is otherwise considered medically significant by the
investigator
Reporting serious adverse events
SAEs believed to be due to surgery (cervical cerclage)
should be reported on a Serious Adverse Event form andfaxed to the COTS study office (this should be the sponsor
or Chief Investigator (CI)). SAEs still present at the end of
the study must be followed up at least until the final out-
come is determined, even if it implies that the follow-up
continues after the patient finishes the study treatment
and, when appropriate, until the end of the planned period
of follow-up. The CI will report all SAEs to the Data Mon-
itoring Committee approximately 3-monthly, to the main
Research Ethics Committee annually, and to the Trial
Steering Committee 6-monthly. Local Investigators are re-
sponsible for reporting SAEs to their host institution, ac-
cording to local regulations, but they do not need to
inform the main Research Ethics Committee as this will be
done by the CI.
Sample size
The size of the pilot study will not allow reliable assess-
ment of the effect of the intervention on clinical out-
comes and so hypothesis testing is not proposed.
In the pilot study, analyses will principally take the
form of simple descriptive statistics of process outcomes,
including eligibility and recruitment rates, and of live
birth rate and secondary clinical outcomes, to aid de-
signing of the main trial. Regression models, appropriate
to the forms of data, will also be fitted, to allow adjust-
ment for covariates.
During the pilot study, accurate assessment of the num-
bers of women eligible, approached and recruited will be
made. The systems and data collection tools will be devel-
oped and piloted. These include the telephone randomisa-
tion system and the collection of the clinical data from
both woman and baby prior to discharge from hospital.
Discussion
We have initiated a pilot/feasibility trial to provide import-
ant information to plan and confidently run a definitive
trial that will be able to determine the clinical and cost ef-
fectiveness of the different types of suture material. We are
aiming to achieve several objectives:
 To test the study protocol that has been designed
with the full scale trial in mind
 Test recruitment and randomization procedures
 Estimate rate of recruitment and attrition in order
to plan the scale and duration of the definitive study
 Examine general data collection, cleaning, input and
analysis procedures
 Establish the benefits of the one type of suture over
the other in cases of elective cervical cerclage.
We will aim to recruit eligible women who agree to
participate in recruiting centres over a 12-month period.
Undoubtedly, the size of the pilot study will not allow
reliable assessment of the effect of the different suture
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of the aims of this study. Nevertheless, we will collect in-
formation from collaborating units on the numbers of
women requiring cervical cerclage and who are eligible
for the study and the birth outcomes of those women.
This will give a larger prospective sample on which to
base the power calculation.
Based on our NRS meta-analysis, the pregnancy loss
rate was 4% and 16% in the multifilament/braided versus
monofilament/non-braided groups, respectively. In view
of the small sample size and lack of randomisation it is
highly likely that this effect size is exaggerated. Based on
49 cases of cerclage using non-braided sutures under-
taken in two large maternity units, the pregnancy loss
rate in this cohort was 5%. In contrast, in the cerclage
group of RCTs included in the Cochrane review where
braided sutures were used as standard, the cumulative
pregnancy loss rate was 13%. Therefore, to demonstrate
a more reserved reduction in this risk from 13 to 5%
with the use of monofilament sutures we will require
267 women in each group (a total of 534 women) with
90% power (P =0.05). To allow for a 10% loss to follow-
up we have increased the total sample size to 600. As-
suming a decline rate of 25%, we will need to approach
800 eligible women to achieve the required sample size
for a full-scale trial to show similar levels of pregnancy.
We are fully aware that the proposed sample size will be
reviewed in light of the results of the pilot study.
If the hypothesised benefit of monofilament sutures is
confirmed, this policy will be rapidly adopted nationally.
In the UK alone this could potentially prevent more than
350 babies per annum dying as a result of mid-trimester
loss, intrauterine infection or complications of prematur-
ity. Moreover, reducing the risk of prematurity will re-
duce neonatal unit and hospital stay, the significant
morbidity associated with early gestation, and the associ-
ated long-term morbidity.
Trial status
Recruitment is ongoing at the time of submission.
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